Kh. Bichler et al., Bilharziasis (schistosomiasis) of the bladder - pathogenesis, diagnostics,therapy and uroprotection, NIEREN HOCH, 28(3), 1999, pp. 102-108
The clinical manifestations of urinary schistosomiasis are related to the l
ife cycle of the parasite Schistosoma haematobium. Chronic infections lasti
ng for years or decades lead to severe changes of the urothelium (inflammat
ion, ulcerating cystitis, retention of urine). In the area of the kidney ne
phritis might occur, rarely also renal insufficiency. The most serious late
sequelae is the development of a bladder carcinoma, especially of che squa
mous cell type. The acute form of bilharziosis is treated by chemotherapy,
mainly by Praziquantel (Biltricide). For preventing severe urothelial damag
e it is necessary to take uroprotective measures. The surface coat of the u
rothelium consists of glycosaminoglycans (GAG) and has important functions
in resisting infections. Therefore, controlled additive treatment with the
uroprotectant D-glucosamine (Dona 200-S) possibly might improve urothelial
damage that occur in urinary schistosomiasis.